Search for author "James Jang"

13 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/24/2017
e.g., 07/24/2017
Format Results
  • Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association. 2016;5:e003576, originally published June 10, 2016
    https://doi.org/10.1161/JAHA.116.003576
  • Open Access
    Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association June 2016, 5 (6) e003576; DOI: https://doi.org/10.1161/JAHA.116.003576
    View table
    Table 1.
    By Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach and John A. Spertus
    Baseline Characteristics of NSTEMI Patients Undergoing DAPT Pretreatment...
    Show More
  • Open Access
    Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association June 2016, 5 (6) e003576; DOI: https://doi.org/10.1161/JAHA.116.003576
    Figure 1.
    Figure 1.
    By Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach and John A. Spertus
    Flow chart of patient selection. CABG indicates coronary artery bypass graft surgery; DAPT, dual antiplatelet therapy; STEMI, ST elevation myocardial...Show More
  • Open Access
    Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association June 2016, 5 (6) e003576; DOI: https://doi.org/10.1161/JAHA.116.003576
    Figure 2.
    Figure 2.
    By Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach and John A. Spertus
    Patient predictors of dual antiplatelet therapy (DAPT) pretreatment. Forest plot depicting the odds ratios of patient level that are associated with o...Show More
  • Open Access
    Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association June 2016, 5 (6) e003576; DOI: https://doi.org/10.1161/JAHA.116.003576
    Figure 3.
    Figure 3.
    By Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach and John A. Spertus
    Graph of site‐level variation for receiving dual antiplatelet therapy (DAPT) pretreatment. The x‐ax...
    Show More
  • Open Access
    Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
    Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach, John A. Spertus
    Journal of the American Heart Association June 2016, 5 (6) e003576; DOI: https://doi.org/10.1161/JAHA.116.003576
    By Ali Shafiq, Javier Valle, Jae‐Sik Jang, Mohammed Qintar, Kensey Gosch, David J. Cohen, Mandeep Singh, Richard Bach and John A. Spertus
    Show More
  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCLINICAL PERSPECTIVEA Randomized, Controlled Trial
    Cheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Seong-Wook Park, Seungbong Han, Sang-Gon Lee, In-Whan Seong, Seung-Woon Rha, Myung-Ho Jeong, Do-Sun Lim, Jung-Han Yoon, Seung-Ho Hur, Yun-Seok Choi, Joo-Young Yang, Nae-Hee Lee, Hyun-Sook Kim, Bong-Ki Lee, Kee-Sik Kim, Seung-Uk Lee, Jei-Keon Chae, Sang-Sig Cheong, Il-woo Suh, Hun-Sik Park, Deuk-Young Nah, Doo-Soo Jeon, Ki-Bae Seung, Keun Lee, Jae-Sik Jang and Seung-Jung Park
    Circulation. 2014;129:304-312, originally published January 20, 2014
    https://doi.org/10.1161/CIRCULATIONAHA.113.003303
  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCLINICAL PERSPECTIVE
    Cheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Seong-Wook Park, Seungbong Han, Sang-Gon Lee, In-Whan Seong, Seung-Woon Rha, Myung-Ho Jeong, Do-Sun Lim, Jung-Han Yoon, Seung-Ho Hur, Yun-Seok Choi, Joo-Young Yang, Nae-Hee Lee, Hyun-Sook Kim, Bong-Ki Lee, Kee-Sik Kim, Seung-Uk Lee, Jei-Keon Chae, Sang-Sig Cheong, Il-woo Suh, Hun-Sik Park, Deuk-Young Nah, Doo-Soo Jeon, Ki-Bae Seung, Keun Lee, Jae-Sik Jang, Seung-Jung Park
    Circulation January 2014, 129 (3) 304-312; DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.003303
    Figure 1.
    Figure 1.
    Study overview. REAL-LATE indicates REAL-world patients treated with drug-eluting stent implantation and Late coronary Arterial Thrombotic Events; and...Show More
  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCLINICAL PERSPECTIVE
    Cheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Seong-Wook Park, Seungbong Han, Sang-Gon Lee, In-Whan Seong, Seung-Woon Rha, Myung-Ho Jeong, Do-Sun Lim, Jung-Han Yoon, Seung-Ho Hur, Yun-Seok Choi, Joo-Young Yang, Nae-Hee Lee, Hyun-Sook Kim, Bong-Ki Lee, Kee-Sik Kim, Seung-Uk Lee, Jei-Keon Chae, Sang-Sig Cheong, Il-woo Suh, Hun-Sik Park, Deuk-Young Nah, Doo-Soo Jeon, Ki-Bae Seung, Keun Lee, Jae-Sik Jang, Seung-Jung Park
    Circulation January 2014, 129 (3) 304-312; DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.003303
    View table
    Table 1.
    Baseline Characteristics of the PatientsShow More
  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCLINICAL PERSPECTIVE
    Cheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Seong-Wook Park, Seungbong Han, Sang-Gon Lee, In-Whan Seong, Seung-Woon Rha, Myung-Ho Jeong, Do-Sun Lim, Jung-Han Yoon, Seung-Ho Hur, Yun-Seok Choi, Joo-Young Yang, Nae-Hee Lee, Hyun-Sook Kim, Bong-Ki Lee, Kee-Sik Kim, Seung-Uk Lee, Jei-Keon Chae, Sang-Sig Cheong, Il-woo Suh, Hun-Sik Park, Deuk-Young Nah, Doo-Soo Jeon, Ki-Bae Seung, Keun Lee, Jae-Sik Jang, Seung-Jung Park
    Circulation January 2014, 129 (3) 304-312; DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.003303
    View table
    Table 2.
    Timing of Randomization and Adherence to the Study Medication(s) in the Clopidogrel+Aspirin and Aspirin-Alone GroupsShow More

Pages

Back to top

Selected Facets

Selected Facets

  • Coronary Heart Disease (Article Type)

Journal

Source

Subject

Subject

Content Type

Resource Type

Advertisement
Advertisement